Hinge Health (HNGE) Competitors

Hinge Health logo
$105.65 -2.45 (-2.27%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$106.73 +1.08 (+1.02%)
As of 11/20/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HNGE vs. LH, DGX, GH, TEM, and BTSG

Should you buy Hinge Health stock or one of its competitors? Hinge Health's main competitors and comparable companies include Labcorp (LH), Quest Diagnostics (DGX), Guardant Health (GH), Tempus AI (TEM), and BrightSpring Health Services (BTSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Hinge Health compare to Labcorp?

Labcorp (NYSE:LH) and Hinge Health (NYSE:HNGE) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

In the previous week, Labcorp had 4 more articles in the media than Hinge Health. MarketBeat recorded 12 mentions for Labcorp and 8 mentions for Hinge Health. Hinge Health's average media sentiment score of 0.97 beat Labcorp's score of 0.47 indicating that Hinge Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Labcorp
5 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hinge Health
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hinge Health has a net margin of 21.02% compared to Labcorp's net margin of 6.88%. Hinge Health's return on equity of 66.96% beat Labcorp's return on equity.

Company Net Margins Return on Equity Return on Assets
Labcorp6.88% 17.13% 7.96%
Hinge Health 21.02%66.96%19.70%

95.9% of Labcorp shares are owned by institutional investors. 0.8% of Labcorp shares are owned by insiders. Comparatively, 18.9% of Hinge Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Labcorp has higher revenue and earnings than Hinge Health. Labcorp is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Labcorp$13.95B2.14$876.50M$12.1930.12
Hinge Health$587.86M14.61-$528.26M$1.9653.90

Labcorp has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market.

Labcorp presently has a consensus price target of $369.08, indicating a potential upside of 0.53%. Hinge Health has a consensus price target of $118.93, indicating a potential upside of 12.57%. Given Hinge Health's stronger consensus rating and higher probable upside, analysts plainly believe Hinge Health is more favorable than Labcorp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Labcorp
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83
Hinge Health
0 Sell rating(s)
2 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.00

Summary

Hinge Health beats Labcorp on 12 of the 17 factors compared between the two stocks.

How does Hinge Health compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Hinge Health (NYSE:HNGE) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

88.1% of Quest Diagnostics shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by insiders. Comparatively, 18.9% of Hinge Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Hinge Health has a net margin of 21.02% compared to Quest Diagnostics' net margin of 9.53%. Hinge Health's return on equity of 66.96% beat Quest Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Quest Diagnostics9.53% 16.21% 7.41%
Hinge Health 21.02%66.96%19.70%

Quest Diagnostics currently has a consensus price target of $248.70, suggesting a potential downside of 3.68%. Hinge Health has a consensus price target of $118.93, suggesting a potential upside of 12.57%. Given Hinge Health's stronger consensus rating and higher possible upside, analysts clearly believe Hinge Health is more favorable than Quest Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quest Diagnostics
0 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.56
Hinge Health
0 Sell rating(s)
2 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.00

Quest Diagnostics has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market.

Quest Diagnostics has higher revenue and earnings than Hinge Health. Quest Diagnostics is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quest Diagnostics$11.84B2.40$992M$10.0425.72
Hinge Health$587.86M14.61-$528.26M$1.9653.90

In the previous week, Quest Diagnostics had 9 more articles in the media than Hinge Health. MarketBeat recorded 17 mentions for Quest Diagnostics and 8 mentions for Hinge Health. Hinge Health's average media sentiment score of 0.97 beat Quest Diagnostics' score of -0.08 indicating that Hinge Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quest Diagnostics
3 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hinge Health
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Hinge Health beats Quest Diagnostics on 12 of the 17 factors compared between the two stocks.

How does Hinge Health compare to Guardant Health?

Hinge Health (NYSE:HNGE) and Guardant Health (NASDAQ:GH) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

In the previous week, Guardant Health had 15 more articles in the media than Hinge Health. MarketBeat recorded 23 mentions for Guardant Health and 8 mentions for Hinge Health. Hinge Health's average media sentiment score of 0.97 beat Guardant Health's score of 0.51 indicating that Hinge Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hinge Health
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardant Health
8 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hinge Health currently has a consensus target price of $118.93, indicating a potential upside of 12.57%. Guardant Health has a consensus target price of $191.48, indicating a potential upside of 31.30%. Given Guardant Health's higher possible upside, analysts clearly believe Guardant Health is more favorable than Hinge Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
0 Sell rating(s)
2 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.00
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
24 Buy rating(s)
1 Strong Buy rating(s)
2.96

Hinge Health has a net margin of 21.02% compared to Guardant Health's net margin of -37.93%. Hinge Health's return on equity of 66.96% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health21.02% 66.96% 19.70%
Guardant Health -37.93%N/A -25.03%

Hinge Health has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.67, suggesting that its share price is 67% more volatile than the broader market.

Guardant Health has higher revenue and earnings than Hinge Health. Guardant Health is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M14.61-$528.26M$1.9653.90
Guardant Health$1.28B15.43-$416.28M-$3.68N/A

92.6% of Guardant Health shares are owned by institutional investors. 18.9% of Hinge Health shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Hinge Health beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Hinge Health compare to Tempus AI?

Hinge Health (NYSE:HNGE) and Tempus AI (NASDAQ:TEM) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends.

In the previous week, Tempus AI had 26 more articles in the media than Hinge Health. MarketBeat recorded 34 mentions for Tempus AI and 8 mentions for Hinge Health. Hinge Health's average media sentiment score of 0.97 beat Tempus AI's score of 0.30 indicating that Hinge Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hinge Health
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tempus AI
13 Very Positive mention(s)
5 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Hinge Health has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.61, indicating that its share price is 261% more volatile than the broader market.

24.2% of Tempus AI shares are owned by institutional investors. 18.9% of Hinge Health shares are owned by insiders. Comparatively, 24.3% of Tempus AI shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Hinge Health presently has a consensus price target of $118.93, indicating a potential upside of 12.57%. Tempus AI has a consensus price target of $79.37, indicating a potential upside of 47.04%. Given Tempus AI's higher possible upside, analysts clearly believe Tempus AI is more favorable than Hinge Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
0 Sell rating(s)
2 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.00
Tempus AI
1 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.45

Tempus AI has higher revenue and earnings than Hinge Health. Tempus AI is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M14.61-$528.26M$1.9653.90
Tempus AI$1.27B7.74-$245.03M-$1.06N/A

Hinge Health has a net margin of 21.02% compared to Tempus AI's net margin of -12.54%. Hinge Health's return on equity of 66.96% beat Tempus AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health21.02% 66.96% 19.70%
Tempus AI -12.54%-47.00%-9.44%

Summary

Hinge Health beats Tempus AI on 10 of the 17 factors compared between the two stocks.

How does Hinge Health compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Hinge Health (NYSE:HNGE) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

Hinge Health has a net margin of 21.02% compared to BrightSpring Health Services' net margin of 2.69%. Hinge Health's return on equity of 66.96% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.69% 18.56% 6.03%
Hinge Health 21.02%66.96%19.70%

BrightSpring Health Services currently has a consensus target price of $78.69, indicating a potential upside of 25.22%. Hinge Health has a consensus target price of $118.93, indicating a potential upside of 12.57%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, equities research analysts plainly believe BrightSpring Health Services is more favorable than Hinge Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
3.11
Hinge Health
0 Sell rating(s)
2 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.00

BrightSpring Health Services has a beta of 1.77, meaning that its stock price is 77% more volatile than the broader market. Comparatively, Hinge Health has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market.

BrightSpring Health Services has higher revenue and earnings than Hinge Health. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B0.97$190.67M$1.8533.97
Hinge Health$587.86M14.61-$528.26M$1.9653.90

In the previous week, BrightSpring Health Services had 2 more articles in the media than Hinge Health. MarketBeat recorded 10 mentions for BrightSpring Health Services and 8 mentions for Hinge Health. Hinge Health's average media sentiment score of 0.97 beat BrightSpring Health Services' score of 0.83 indicating that Hinge Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Hinge Health
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

BrightSpring Health Services and Hinge Health tied by winning 7 of the 14 factors compared between the two stocks.

Get Hinge Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HNGE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HNGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HNGE vs. The Competition

MetricHinge HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$8.60B$9.75B$7.43B$20.37B
Dividend YieldN/A2.58%2.51%3.98%
P/E Ratio53.9032.3132.5627.91
Price / Sales14.611.918.103.49
Price / CashN/A21.6320.2514.62
Price / Book28.713.574.343.40
Net Income-$528.26M$329.93M$3.51B$1.07B
7 Day Performance-8.30%-7.06%-8.07%-7.13%
1 Month Performance-4.11%-7.73%-10.29%-7.56%
1 Year Performance129.52%10.82%-4.70%0.53%

Hinge Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HNGE
Hinge Health
3.0878 of 5 stars
$105.65
-2.3%
$118.93
+12.6%
+129.5%$8.60B$587.86M53.901,437
LH
Labcorp
2.7389 of 5 stars
$371.68
+1.4%
$369.08
-0.7%
+38.1%$30.18B$13.95B30.4971,000
DGX
Quest Diagnostics
2.5677 of 5 stars
$259.28
+1.4%
$248.70
-4.1%
+35.1%$28.53B$11.04B25.8357,000
GH
Guardant Health
3.7682 of 5 stars
$158.79
+5.2%
$191.00
+20.3%
+38.3%$21.31B$982.02MN/A2,506
TEM
Tempus AI
3.118 of 5 stars
$84.44
+11.0%
$79.37
-6.0%
-23.2%$15.24B$1.51BN/A3,800

Related Companies and Tools


This page (NYSE:HNGE) was last updated on 11/22/2026 by MarketBeat.com Staff.
From Our Partners